feed,title,long_url,short_url
SeekingAlpha,"Inhibrx Biosciences, Inc. GAAP EPS of $125.40, revenue of $100M",https://seekingalpha.com/news/4139918,
SeekingAlpha,Federal Reserve Cuts: What Bond Investors Need To Know,https://seekingalpha.com/article/4714498,
SeekingAlpha,Understanding CBI's Green Bond Dataset Methodology,https://seekingalpha.com/article/4714531,
SeekingAlpha,EPAM Systems: Slowing Revenue But AI Innovations Make It One To Watch,https://seekingalpha.com/article/4714494,
